Clinical trial NCT03840213: Nutrition and Chemotherapy
Official title: Nutrition and Chemotherapy, Representation and Practice in a Cancer Care Centre (JEUNETCHIMIO)
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Cancer
Keywords: Chemotherapy
nutrition
self-care
care/caregiver relationship
fasting
Lead sponsor: Institut de Cancérologie de la Loire
Sponsor class: OTHER
Collaborators: name: Ligue contre le cancer, France
First posted: 2019-02-15
Enrollment: 200
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients who intend to practice, or who practice a form of fasting during their chemotherapy treatment will be proposed to participate to a qualitative study to collect more information about their fasting.

Brief summary: Patients treated for cancer nowadays have many means of information and tend to become more and more involved in their health. The interest of a therapeutic fast with detoxifying or even curative properties, with a specific indication for cancer patients treated by chemotherapy, is nowadays relayed by the media. To date, there are no studies conducted on the scope of this information in cancer patients or on the attitudes of oncologists towards this practice and possible positioning requests from patients.

We hypothesize that the choice of this practice and its modalities are rarely discussed with oncologists, although it may have deleterious repercussions on the patient's health.

We propose a research based on the principles of sociological intervention. Its objectives are a first review of the issue and the establishment of a joint working group, including patients, carers and researchers, which will propose solutions to improve the patient/carer dialogue on this issue.

Detailed description: Patients treated for cancer nowadays have many means of information and tend to become more and more involved in their health. The interest of a therapeutic fast with detoxifying or even curative properties, with a specific indication for cancer patients treated by chemotherapy, is nowadays relayed by the media. To date, there are no studies conducted on the scope of this information in cancer patients or on the attitudes of oncologists towards this practice and possible positioning requests from patients.

We hypothesize that the choice of this practice and its modalities are rarely discussed with oncologists, although it may have deleterious repercussions on the patient's health.

We propose a research based on the principles of sociological intervention. Its objectives are a first review of the issue and the establishment of a joint working group, including patients, carers and researchers, which will propose solutions to improve the patient/carer dialogue on this issue.

Eligibility criteria: Inclusion Criteria:

* Major patients, follow-up on Institut de Cancerology Lucien Neuwirth day service chemotherapy treatment
* Patient affiliated or entitled to a social security scheme
* Patient who received informed information about the study
* Patient able to read French

Patients participating in the qualitative study:

Exclusion Criteria:

* Refusal to participate, protected adult person, under guardianship or curatorship
* Person unable to understand the conduct of the study
* Person with a documented history of cognitive or psychiatric disorders

Primary outcomes:
measure: Number of patients who voluntarily changed their eating habits
timeFrame: 1 year
Secondary outcomes:
measure: Number of patients on therapeutic fasting or restrictive diet during chemotherapy treatment
timeFrame: 1 year
measure: Number of patients using complementary or alternative medicines
timeFrame: 1 year
measure: Number of patients discussing these different practices with their oncologist
timeFrame: 1 year
measure: Number of patients discussing these different practices with other caregivers
timeFrame: 1 year
Other outcomes:
Locations:
city: Saint-Priest-en-Jarez
country: France
facility: Institut de Cancérologie Lucien Neuwirth
Study officials:
affiliation: Institut de Cancérologie Lucien Neuwirth
name: Pierre Fournel, MD
role: PRINCIPAL_INVESTIGATOR
References: